未找到相关数据
Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) For Relapsed/Refractory Hodgkin Lymphoma (HL) In The Brentuximab Vedotin Era: Favorable Overall and Progression-Free Survival (OS/PFS) With Low Transplant-Related Mortality (TRM)
被引：8
作者：
Anderlini, Paolo
Saliba, Rima M.
Ledesma, Celina
Chancoco, Christina M.
Alexander, Tamera
Alousi, Amin
Hosing, Chitra M.
Khouri, Issa
Nieto, Yago
Popat, Uday R.
Shpall, Elizabeth J.
Fanale, Michelle A.
Oki, Yasuhiro
Romaguera, Jorge E.
Neelapu, Sattva
Younes, Anas
Champlin, Richard E.
机构：
来源：
关键词：
D O I：
10.1182/blood.V122.21.410.410
中图分类号：
R5 [内科学];
学科分类号：
100201 [内科学];
摘要：
410
引用
收藏
页数：2
相关论文